NCT07004946

Brief Summary

This study uses CelTouch to explore patients with lung lesions scheduled for lung biopsy. By comparing with preclinical CLE images and pathological images, CLE diagnostic criteria for benign and malignant lung lesions under the microscope will be established; the performance of CLE in diagnosing peripheral lung lesions will be validated through multicenter clinical research; and a CLE atlas for peripheral lung lesions will be constructed to establish a visual classification diagnostic system for peripheral lung lesions. (1) Comparative Study of In Vivo CLE Images and Pathological Images in the Diagnosis of Peripheral Lung Lesions

  1. 1.Collect CLE images and histopathological sections of clearly diagnosed peripheral lung lesions.
  2. 2.A diagnostic team composed of 1 bronchoscopy expert, 1 pathology expert, and 2 CLE experts will correlate in vivo and ex vivo CLE images of lung lesions with corresponding pathological images, analyze CLE image characteristics of benign and malignant lung lesions, and establish CLE diagnostic criteria for benign and malignant lung lesions.
  3. 3.Multicenter screening of corresponding subjects according to inclusion and exclusion criteria, collection of corresponding videos and images during surgery, and recording of observed characteristic images based on pre-established diagnostic characteristics and criteria.
  4. 4.The diagnostic team and sub-center representatives (5 in total) will perform offline interpretation of the collected images and videos, and evaluate the diagnostic performance of CLE in peripheral lung lesions using the accurate diagnostic results obtained from postoperative histopathology or 6-month clinical follow-up as the standard.
  5. 5.Establishment of a CLE Atlas and Classification System for Lung Lesions

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
286

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
May 2025Dec 2026

First Submitted

Initial submission to the registry

May 26, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

May 31, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

May 26, 2025

Last Update Submit

May 26, 2025

Conditions

Keywords

peripheral pulmonary lesion

Outcome Measures

Primary Outcomes (1)

  • Diagnostic yield

    diagnostic yield=(The number of cases with a definitive diagnosis / The total number of cases enrolled in the trial) × 100%

    6 months after procedure

Study Arms (1)

Confocal laser endomicroscopy group

Utilize confocal laser endomicroscopy for the examination of peripheral lung lesions in patients.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. All subjects have completed CelTouch examination 2. Each subject has obtained a clear histological diagnosis or clinical follow-up diagnosis for 6 months

You may qualify if:

  • Aged ≥18 years, with lung lesions detected by chest CT and scheduled for lung biopsy;
  • Preoperative CT indicates the presence of a bronchus leading to the lesion to be biopsied;
  • Able to understand and willing to sign a written informed consent form. -

You may not qualify if:

  • Those with contraindications to general anesthesia or bronchoscopy;
  • Patients with uncorrectable coagulation disorders;
  • Unable to discontinue therapeutic anticoagulants within an appropriate time interval before surgery;
  • Patients with severe liver or kidney dysfunction, cardiovascular and cerebrovascular diseases, mental illnesses, etc.;
  • Pregnant or lactating patients;
  • Those without a clear histological or clinical diagnosis;
  • Subjects deemed unsuitable by the investigator. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510163

Guangzhou, Guangdong, 510100, China

RECRUITING

Related Publications (1)

  • Wijmans L, Yared J, de Bruin DM, Meijer SL, Baas P, Bonta PI, Annema JT. Needle-based confocal laser endomicroscopy for real-time diagnosing and staging of lung cancer. Eur Respir J. 2019 Jun 20;53(6):1801520. doi: 10.1183/13993003.01520-2018. Print 2019 Jun.

    PMID: 31023849BACKGROUND

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 26, 2025

First Posted

June 4, 2025

Study Start

May 31, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 4, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations